Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Chronic Lymphocytic Leukemia (CLL) Driver Genes: Risk of CLL and Monoclonal B-Cell Lymphocytosis (MBL)

被引：0
|
作者：
Boddicker, Nicholas J. [1 ]
O'Brien, Daniel R. [2 ]
Braggio, Esteban [3 ]
Achenbach, Sara J. [1 ]
Chaffee, Kari G. [1 ]
Norman, Aaron D. [1 ]
Vachon, Celine M. [4 ]
Kabat, Brian [5 ]
Call, Timothy G. [6 ]
Parikh, Sameer A. [6 ]
Leis, Jose F. [7 ]
Ding, Wei [2 ]
Muchtar, Eli [6 ]
Cerhan, James R. [2 ]
Shanafelt, Tait D. [8 ]
Kay, Neil E. [6 ]
Caporaso, Neil E. [9 ]
Slager, Susan L. [1 ]
机构：
[1] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
[2] Mayo Clin, Rochester, MN USA
[3] Mayo Clin, Div Hematol & Oncol, Scottsdale, AZ USA
[4] Mayo Clin, Div Epidemiol, Rochester, MN USA
[5] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA
[6] Mayo Clin, Div Hematol, Rochester, MN USA
[7] Mayo Clin, Div Hematol & Med Oncol, Phoenix, AZ USA
[8] Stanford Univ, Stanford, CA 94305 USA
[9] NCI, NIH, DHHS, Bethesda, MD 20892 USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-117044
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3116
引用
收藏
页数：3
相关论文
共 50 条
  • [21] CD49D EXPRESSION IS ASSOCIATED WITH DEVELOPMENT OF LYMPHADENOPATHY IN PATIENTS WITH MONOCLONAL B-CELL LYMPHOCYTOSIS (MBL) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    Strati, P.
    Chaffee, K.
    Achenbach, S.
    Slager, S.
    Call, T.
    Kay, N.
    Ding, W.
    Parikh, S.
    Jelinek, D.
    Hanson, C.
    Shanafelt, T.
    HAEMATOLOGICA, 2016, 101 : 435 - 436
  • [22] Chronic Lymphocytic Leukaemia (CLL) and CLL-Type Monoclonal B-Cell Lymphocytosis (MBL) Show Differential Expression of Molecules Involved in Lymphoid Tissue Homing
    Rawstron, Andy C.
    Shingles, Jane
    de Tute, Ruth
    Bennett, Fiona
    Jack, Andrew S.
    Hillmen, Peter
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2010, 78B : S42 - S46
  • [23] Age-related clonal hematopoiesis and monoclonal B-cell lymphocytosis / chronic lymphocytic leukemia: a new association?
    Condoluci, Adalgisa
    Rossi, Davide
    HAEMATOLOGICA, 2018, 103 (05) : 751 - 752
  • [24] Serum Immunoglobulins Are an Independent Prognostic Marker of Time to First Therapy in Newly Diagnosed Chronic Lymphocytic Leukemia (CLL) and Monoclonal B-Cell Lymphocytosis (MBL)
    Yao, Yuan
    Rabe, Kari G.
    Allmer, Cristine
    Kleinstern, Geffen
    Boddicker, Nicholas J.
    Tian, Shulan
    Bruins, Laura A.
    O'Brien, Daniel R.
    Norman, Aaron D.
    Yan, Huihuang
    Call, Timothy G.
    Hampel, Paul J.
    Wang, Yucai
    Muchtar, Eli
    Kenderian, Saad S.
    Kay, Neil E.
    Vachon, Celine M.
    Cerhan, James R.
    Slager, Susan L.
    Braggio, Esteban
    Parikh, Sameer A.
    BLOOD, 2024, 144 : 4616 - 4617
  • [25] The prevalence of non-chronic lymphocytic leukemia (CLL) phenotype monoclonal B-cell lymphocytosis (MBL) in a population-based cohort of US adults
    Parikh, Sameer A.
    Achenbach, Sara J.
    Chaffee, Kari G.
    Kay, Neil E.
    Lesnick, Connie E.
    Cerhan, James R.
    Hanson, Curtis A.
    Shanafelt, Tait D.
    Slager, Susan L.
    CANCER RESEARCH, 2018, 78 (13)
  • [26] Serum immunoglobulins are an independent prognostic marker of time to first therapy in newly diagnosed chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis (MBL)
    Parikh, Sameer A.
    Allmer, Cristine
    Kleinstern, Geffen
    Boddicker, Nicholas J.
    Tian, Shulan
    De Campos, Cecilia B.
    Bruins, Laura A.
    o''Brien, Daniel R.
    Kabat, Brian F.
    Rabe, Kari G.
    Norman, Aaron D.
    Yan, Huihuang
    Li, Xing
    Call, Timothy G.
    Ding, Wei
    Leis, Jose F.
    Kenderian, Saad J.
    Vachon, Celine M.
    Cerhan, James R.
    Kay, Neil E.
    Slager, Susan L.
    Braggio, Esteban
    CANCER RESEARCH, 2020, 80 (16)
  • [27] B-CELL COUNT AND TIME TO FIRST TREAMENT: DIFFERENTIATING CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) FROM MONOCLONAL B-CELL LYMPHOCYTOSIS (MBL) BASED ON CLINICAL OUTCOME: THE GIMEMA EXPERIENCE
    Molica, S.
    Mauro, F.
    Callea, V.
    Giannarelli, D.
    Lauria, F.
    Cortelezzi, A.
    Liso, V.
    Foa, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 328 - 328
  • [28] Monoclonal B-cell lymphocytosis (MBL) in CLL families: substantial increase in relative risk for young adults
    R de Tute
    M Yuille
    D Catovsky
    R S Houlston
    P Hillmen
    A C Rawstron
    Leukemia, 2006, 20 : 728 - 729
  • [29] Monoclonal B-cell lymphocytosis (MBL) in CLL families: substantial increase in relative risk for young adults
    de Tute, R
    Yuille, M
    Catovsky, D
    Houlston, RS
    Hillmen, P
    Rawstron, AC
    LEUKEMIA, 2006, 20 (04) : 728 - 729
  • [30] y Reduced Expression of the CD94/NKG2C NK Cell Receptor in Chronic Lymphocytic Leukemia (CLL) and CLL-like Monoclonal B-Cell Lymphocytosis (MBL)
    Puiggros, Anna
    Blanco, Gonzalo
    Muntasell, Aura
    Rodriguez-Rivera, Maria
    Nonell, Lara
    Puigdecanet, Eulalia
    Arnal, Magdalena
    Calvo, Xavier
    Gimeno, Eva
    Abella, Eugenia
    Abrisqueta, Pau
    Bosch, Francesc
    Yelamos, Jose
    Ferrer, Ana
    Lopez-Botet, Miguel
    Espinet, Blanca
    BLOOD, 2019, 134
12345